Psoriasis

The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.

Latest News

Plaque psoriasis | Image credit: Milan Lipowski - stock.adobe.com
Defining On-Treatment Remission in Plaque Psoriasis

June 18th 2025

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Adalimumab | Image credit: luchschenF - stock.adobe.com
Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests

June 16th 2025

Psoriasis | Image credit: SergeVo - stock.adobe.com
Low BSA in Psoriasis May Still Mean High Disease Burden

June 12th 2025

Psoriasis skin, eczema, rash and other skin diseases. | Image credit: stockmaster - stock.adobe.com.jpg
Patients With GPP Face Elevated Mortality Risk, Study Finds

June 3rd 2025

woman with psoriasis | Image credit: Andrey Popov - stock.adobe.com
Biosimilar Starjemza Gains FDA Approval as Ustekinumab Shows Significant Psoriasis-Itch Relief

May 29th 2025

A Personalized Approach to Disease Management in Psoriasis

A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.

Ryan Haumschild, PharmD, MS, MBA, Bhavesh Shah, PharmD, Mark Lebwohl, MD, and Robert Groves, MD.
Continuing Medical Education
View All
July 2nd 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
July 2nd 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology
July 2nd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 2nd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Psoriasis patch on hand.
August 6th 2021

Analysis Finds Elevated Risk of Psoriasis, Psoriatic Arthritis in Patients With Uveitis

Matthew Gavidia
Taiwanese patients with uveitis were shown to be at greater risk of developing psoriasis and psoriatic arthritis than the general population, and hypertension, diabetes, and obesity were more prominent in these populations as well.
Person measuring body fat.
July 29th 2021

Obesity Linked With Lower QOL, Greater Disease Burden in Patients With Psoriatic Arthritis

Matthew Gavidia
Patients with psoriatic arthritis and rheumatoid arthritis who were obese were shown to present with significantly lower quality of life (QOL) and worse disease activity than those with normal weight.
Hospital floor setting.
July 21st 2021

Infliximab, Adalimumab Use Associated With Risk of Serious Infection in Patients With Psoriasis

Matthew Gavidia
New users of infliximab and adalimumab who had moderate to severe psoriasis exhibited an increased risk of hospitalization due to serious infection compared with etanercept users, with use of ustekinumab conversely linked with a decreased risk.
files on shelf
July 17th 2021

Assessing Performance of Psoriasis, Atopic Dermatitis Questionnaires Over Time

Gianna Melillo
Researchers investigated whether responses to questionnaires on psoriasis and atopic dermatitis prevalence remained consistent over time.
Young adults.
July 15th 2021

Low Fitness in Young Adults May Increase Risk of Psoriasis Later in Life

Matthew Gavidia
Low cardiorespiratory fitness among young adult men was significantly associated with an increased risk of psoriasis and psoriatic arthritis over 3 decades.
blood vessel
July 10th 2021

Patients With Psoriatic Arthritis Have Altered Hemostatic Function, Analysis Finds

Jared Kaltwasser
The new report may help explain why patients with psoriasis have a higher risk of cardiovascular problems.
Psoriasis One of the Most Common Immune-Mediated Diseases Affecting US Adults
July 8th 2021

Psoriasis One of the Most Common Immune-Mediated Diseases Affecting US Adults

Lauren Massaro
Psoriasis is prevalent among more than 7.5 million adults in the United States, a new study says.
Hand with psoriasis
June 29th 2021

Case Reports: Off-label Tildrakizumab Effective in Nail Psoriasis

Jared Kaltwasser
A new report suggests patients with persistent nail psoriasis may benefit from biologics like tildrakizumab.
man with dry itchy skin scratching his hand
June 26th 2021

Psoriasis Recap: Updated COVID-19 Guidance, Guselkumab Study Results, and More

Skylar Jeremias
Recent reports document new COVID-19 guidance for people with psoriatic disease, positive safety and efficacy results for guselkumab, and findings linking the C-Jun protein with psoriasis.
Doctor reviewing treatment with a patient
June 23rd 2021

Study: Alcohol Abuse Associated With Poor Therapeutic Response in Psoriasis

Jared Kaltwasser
Alcohol abuse, obesity, and the use of systemic therapies instead of biologics were all linked with poor response among individuals with psoriasis.
Systemic Therapies Linked With Herpes Zoster Risk in Patients With Psoriasis
June 16th 2021

Systemic Therapies Linked With Herpes Zoster Risk in Patients With Psoriasis

Jared Kaltwasser
Three biologics appeared to increase herpes zoster risk, but 2 other therapies were shown to lower the risk, according to a study of patients in a Taiwanese national database.
image of heart
June 11th 2021

Review: Patients With Psoriatic Arthritis Have Increased Rates of Metabolic Syndrome

Gianna Melillo
Results of a systematic review and meta-analysis point to higher rates of metabolic syndrome among patients with psoriatic arthritis.
Patient history form
May 29th 2021

Exploring the Common Characteristics in Psoriasis and Vitiligo

Allison Inserro
Both conditions involve a genetic predisposition as well as immune pathways that are triggered by environmental factors.
people graphic
May 26th 2021

A Look at Personalized Therapy for Psoriatic Arthritis

Larry Hanover
A review detailed the initial steps taken into personalized therapeutic options for psoriatic arthritis.
Psoriasis Recap: Investigational Therapies for GPP; How Patients View Remission in PsA
May 22nd 2021

Psoriasis Recap: Investigational Therapies for GPP; How Patients View Remission in PsA

AJMC Staff
Generalized pustular psoriasis (GPP) may have therapies in a few years; how patients define remission in psoriatic arthritis (PsA).
Untreated Psoriasis and a Cardiac Connection: Lessons From a Case Report
May 21st 2021

Untreated Psoriasis and a Cardiac Connection: Lessons From a Case Report

Larry Hanover
A case of a patient with untreated psoriasis and nonischemic dilated cardiomyopathy (NIDCM) prompted clinicians to encourage study of the rare combination of disease.
Psoriasis Recap: Intermittent Fasting, Microbiome-Skin Links, and More
May 15th 2021

Psoriasis Recap: Intermittent Fasting, Microbiome-Skin Links, and More

AJMC Staff
Updates from 2 recent medical meetings about links between the gut, psoriasis, and other skin disease, as well as the risk of COVID-19.
Pediatric study links psoriasis and T1D
May 14th 2021

Pediatric Study Links Psoriasis, T1D

Larry Hanover
Psoriasis may be associated with an increased prevalence of type 1 diabetes (T1D).
Study looks at role of IL-30 in psoriasis
May 3rd 2021

Study Examines Role of Interleukin-30 in Psoriasis

Larry Hanover
Patients with psoriasis have a higher level of interleukin-30 (IL-30) than healthy patients, according to a recent study.
Longer PASI90 Duration Associated With Better PROs for Patients With Psoriasis
May 1st 2021

Longer PASI90 Duration Associated With Better PROs for Patients With Psoriasis

AJMC Staff
Each month of duration of 90% or more improvement in Psoriasis Are and Severity Index significantly impacted patient-reported outcomes in patients with psoriasis.
COVID-19 Had Negative Impact on Psoriasis Care, Prescription Patterns, Survey Says
April 23rd 2021

COVID-19 Had Negative Impact on Psoriasis Care, Prescription Patterns, Survey Says

Allison Inserro
Egyptian dermatologists were asked about the effect of COVID‐19 on prescription patterns, appointment rescheduling, therapy decisions, and telemedicine use.
Tildrakizumab Shows Long-term Safety, Efficacy in Patients With Plaque Psoriasis in Japan
April 23rd 2021

Tildrakizumab Shows Long-term Safety, Efficacy in Patients With Plaque Psoriasis in Japan

Jaime Rosenberg
The long-term findings come from a subgroup analysis of 120 patients in Japan taking part in an extension of the 3-part, double-blind, randomized, controlled reSURFACE 1 trial.
Case Study Describes Importance of Distinguishing PsA From Other Disorders
April 17th 2021

Case Study Describes Importance of Distinguishing PsA From Other Disorders

AJMC Staff
If left untreated, patients with psoriatic arthritis (PsA) are at risk of irreversible joint damage, cardiovascular disease, and death. Some other conditions conflated with PsA include chronic eczema, seborrheic dermatitis, onychomycosis, lichen planus, and nodular prurigo.
Hands with psoriasis
April 15th 2021

Patients With Psoriasis May Benefit From Long-term Treatment With Tildrakizumab

Larry Hanover
Ilumya (tildrakizumab) was shown to be safe and effective in controlling moderate to severe psoriasis for adults through 5 years of treatment in a recent study.
Study Shows Higher Incidence of Psoriasis in Patients With PCOS
June 30th 2020

Study Shows Higher Incidence of Psoriasis in Patients With PCOS

Skylar Jeremias
A Taiwanese study revealed that attributes associated with polycystic ovary syndrome (PCOS) may increase the risks of those patients developing psoriasis as well.
Certain Personality Traits in Patients With Psoriasis May Explain Social Anxiety
June 30th 2020

Certain Personality Traits in Patients With Psoriasis May Explain Social Anxiety

Skylar Jeremias
A study analyzing patients with psoriasis revealed that personality traits may have a greater impact on the development of social anxiety than disease severity.
Patient Survey Shows Impact of Psoriatic Arthritis Varies Globally
June 20th 2020

Patient Survey Shows Impact of Psoriatic Arthritis Varies Globally

Skylar Jeremias
The impact of psoriatic arthritis on quality of life can vary depending on geographic location and culture, according to a global patient survey.
Treatment With TNF Inhibitors Does Not Reduce Risk of Developing Psoriatic Arthritis After Psoriasis
June 19th 2020

Treatment With TNF Inhibitors Does Not Reduce Risk of Developing Psoriatic Arthritis After Psoriasis

Laura Joszt, MA
In 90% of patients, psoriasis precedes psoriatic arthritis by an average of 7 years, providing a window of opportunity for early intervention and possible prevention of psoriatic arthritis.
Immunosuppressive Psoriatic Drugs Don't Increase Risks for COVID-19 Complications
June 13th 2020

Immunosuppressive Psoriatic Drugs Don't Increase Risks for COVID-19 Complications

Skylar Jeremias
Authors of an opinion piece concluded that not only are immunosuppressed patients with psoriasis not at an increased risk of developing serious complications related to coronavirus disease 2019 (COVID-19), their medications may help mitigate potential issues.
What Is the Impact of Psoriasis on Patients' Mental Health?
June 12th 2020

What Is the Impact of Psoriasis on Patients' Mental Health?

Laura Joszt, MA
Patients with psoriasis often have other physical diseases, and these somatic comorbidities can have a bigger effect on the patient’s mental health than the skin symptoms from their psoriasis, according to a study published in JAMA Dermatology.
<1
...
6789101112131415>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo